Calgary, Alberta--(Newsfile Corp. - September 3, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0), the leading autologous (patient's…
Filing based on pivotal Phase 3 ORCA-2 and ORCA-3 clinical trials demonstrating statistically significant and clinically meaningful smoking cessation FDA…
NEW YORK, Sept. 2, 2025 /PRNewswire/ -- 'A Moment of Xen', the acclaimed Tri-State talk show hosted by celebrated media…
Neurophet's AI-based brain imaging analysis solutions to support global standardization of Alzheimer's and other dementia-related dataEnhancing dementia research by integrating…
Zug, Switzerland--(Newsfile Corp. - September 2, 2025) - Longevity Investors, launched back in 2020 as the first industry event series…
Approvals mark a major milestone and bring the most advanced image quality to date to Swoop® system users in European…
Approvals mark a major milestone and bring the most advanced image quality to date to Swoop® system users in European…
Adoption of Illumina's MiSeq i100 Plus accelerates results delivery to next-day from sample receipt, speeding up patient care when time…
NRx CEO presented plans for HOPE Therapeutics rollout in September 2025 and establishment of flagship location in Palm Beach, FL…
Illustrative image Laboratory, Boehringer Ingelheim This press release is not intended for UK and US media. HERNEXEOS® (zongertinib tablets) has been…